33 results
424B5
n8obv
15 Nov 23
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
6reimnf2vk
14 Nov 23
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update
4:05pm
8-K
EX-99.1
ffr5yz2w78272sm t1fq
3 Nov 23
Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection
4:05pm
424B3
iqwmigxs97efl
13 Jul 23
Prospectus supplement
4:32pm
424B5
rwhvhhdsdy3
17 May 23
Prospectus supplement for primary offering
4:25pm
424B3
cs6xheu yz1gnd8cju
23 Sep 22
Prospectus supplement
8:19am
424B5
0axt qn39gfkbfawfp6
25 Jul 22
Prospectus supplement for primary offering
4:26pm
8-K
EX-99.1
kzpk5vhbr w9kn9
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am